Literature DB >> 27285378

Rational Design of Multi-Stimuli-Responsive Nanoparticles for Precise Cancer Therapy.

Xiaonan An1, Aijun Zhu1, Huanhuan Luo1, Hengte Ke1, Huabing Chen1, Youliang Zhao1.   

Abstract

Stimuli-responsive nanoparticles with target capacity are of great interest in drug delivery for cancer therapy. However, the challenge is to achieve highly smart release with precise spatiotemporal control for cancer therapy. Herein, we report the preparation and properties of multi-stimuli-responsive nanoparticles through the co-assembly of a 3-arm star quaterpolymer with a near-infrared (NIR) photothermal agent and chemotherapeutic compound. The nanoparticles can exhibit NIR light/pH/reduction-responsive drug release and intracellular drug translocation in cancer cells, which further integrate photoinduced hyperthermia for synergistic anticancer efficiency, thereby leading to tumor ablation without tumor regrowth. Thus, this rational design of nanoparticles with multiple responsiveness represents a versatile strategy to provide smart drug delivery paradigms for cancer therapy.

Entities:  

Keywords:  cancer therapy; miktoarm star copolymer; multisensitive nanoparticles; stimuli-triggered release; synergistic effect

Mesh:

Substances:

Year:  2016        PMID: 27285378     DOI: 10.1021/acsnano.6b01296

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  20 in total

Review 1.  Hydroxyethyl starch and its derivatives as nanocarriers for delivery of diagnostic and therapeutic agents towards cancers.

Authors:  Ronghua Tan; Ying Wan; Xiangliang Yang
Journal:  Biomater Transl       Date:  2020-12-28

Review 2.  Stimuli-responsive nanocarriers for therapeutic applications in cancer.

Authors:  Xubo Zhao; Jie Bai; Wenjing Yang
Journal:  Cancer Biol Med       Date:  2021-03-25       Impact factor: 4.248

Review 3.  Design, challenge, and promise of stimuli-responsive nanoantibiotics.

Authors:  Julius A Edson; Young Jik Kwon
Journal:  Nano Converg       Date:  2016-10-15

Review 4.  Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer.

Authors:  Kangkang Ying; Bingjun Bai; Xing Gao; Yuzi Xu; Hangxiang Wang; Binbin Xie
Journal:  Front Bioeng Biotechnol       Date:  2021-07-07

Review 5.  Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy.

Authors:  Di Chang; Yuanyuan Ma; Xiaoxuan Xu; Jinbing Xie; Shenghong Ju
Journal:  Front Bioeng Biotechnol       Date:  2021-06-25

6.  Construction of A Triple-Stimuli-Responsive System Based on Cerium Oxide Coated Mesoporous Silica Nanoparticles.

Authors:  Jia Wen; Kui Yang; Yongqian Xu; Hongjuan Li; Fengyu Liu; Shiguo Sun
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

7.  Molecularly precise self-assembly of theranostic nanoprobes within a single-molecular framework for in vivo tracking of tumor-specific chemotherapy.

Authors:  Chenxu Yan; Zhiqian Guo; Yanyan Shen; Yi Chen; He Tian; Wei-Hong Zhu
Journal:  Chem Sci       Date:  2018-04-24       Impact factor: 9.825

8.  In Situ Monitoring of MicroRNA Replacement Efficacy and Accurate Imaging-Guided Cancer Therapy through Light-Up Inter-Polyelectrolyte Nanocomplexes.

Authors:  Xiongwei Deng; Zhaoxia Yin; Jianqing Lu; Xianlei Li; Leihou Shao; Caiyan Zhao; Yishu Yang; Qin Hu; Yan Wu; Wang Sheng
Journal:  Adv Sci (Weinh)       Date:  2018-01-19       Impact factor: 16.806

9.  Sequential Delivery of Cyclopeptide RA-V and Doxorubicin for Combination Therapy on Resistant Tumor and In Situ Monitoring of Cytochrome c Release.

Authors:  Huachao Chen; Yurong Wang; Yongrong Yao; Shenglin Qiao; Hao Wang; Ninghua Tan
Journal:  Theranostics       Date:  2017-08-23       Impact factor: 11.556

10.  Idarubicin-loaded methoxy poly(ethylene glycol)-b-poly(l-lactide-co-glycolide) nanoparticles for enhancing cellular uptake and promoting antileukemia activity.

Authors:  Bin Liang; Na Li; Shuofei Zhang; Aihua Qi; Jianhua Feng; Weiwei Jing; Changcan Shi; Zhaipu Ma; Shenmeng Gao
Journal:  Int J Nanomedicine       Date:  2019-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.